Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Plasmanate 5% Infusion

Prescription Icon
Prescription Required

Marketer

Bharat Serums & Vaccines Ltd

Salt Composition

Albumin (5%)

Overview Plasmanate 5% Infusion

Human albumin 5% solution is indicated for the management of hypovolemia. Its mechanism involves replenishing fluids depleted by significant trauma, hemorrhage, surgical procedures, or hemodialysis. Consequently, it's beneficial in addressing hypoalbuminemia. Administration of Human albumin 5% solution requires strict medical oversight. Contraindicated in patients with known allergies to this product, it necessitates informing your physician of any pre-existing severe cardiac conditions prior to use. Your physician will likely monitor blood pressure and order periodic blood tests during treatment. Common adverse reactions encompass flushing, nausea, emesis, rigors, and pyrexia. Disclose any pregnancy, lactation, or renal impairment to your doctor; dosage modification may be necessary for the latter. This solution is considered safe for individuals with hepatic disease.

Uses of Plasmanate 5% Infusion

Post-trauma hydration management

Major Benefits of Plasmanate 5% Infusion:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Plasmanate 5% Infusion:

  • Vomiting
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Fever
  • Nausea
  • Chills
  • Hives

How to use Plasmanate 5% Infusion:

The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Plasmanate 5% Infusion works:

Human albumin, a naturally occurring blood protein, is the key component of Plasmanate 5% Infusion. This infusion replenishes blood volume and bodily fluids depleted by significant blood loss, surgical procedures, or kidney dialysis.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Plasmanate 5% Infusion lacks established safety data. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

The safety of 5% Plasmanate Infusion during pregnancy is uncertain. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to any prescription. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of 5% Plasmanate infusion with breastfeeding is currently unavailable. Seek medical advice from your physician.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should receive 5% Plasmanate infusion with careful monitoring. Dosage modification of 5% Plasmanate infusion may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The administration of 5% Plasmanate infusion presents no safety concerns for individuals with hepatic impairment. No alteration in Plasmanate 5% infusion dosage is advised.

What if you forget to take Plasmanate 5% Infusion :

Omit a Plasmanate 5% Infusion dose? Seek your physician's advice.

Facts to Know About Plasmanate 5% Infusion

LabelValue
Type of Compound Proteins' Building Blocks: Amino Acids, Their Chains (Peptides), and Related Compounds
Potential for Dependence None.
Type of Medication Hematological

FAQs on Plasmanate 5% Infusion

Prior to administering this medication, disclose any allergies to albumin-based products or any constituent of this drug. If an allergic or anaphylactic reaction is suspected, the infusion must be halted immediately.
Prior to administering this injection, your healthcare provider will assess your vital signs, including blood pressure and heart rate, and perform blood work to verify appropriate dosage. Report any headache, respiratory distress, or elevated blood pressure to your physician without delay.
Intravenous administration of this medication should not surpass 1 mL per minute in patients with typical blood volume to mitigate the potential for circulatory overload and resultant pulmonary edema.
Plasmanate 5% Infusion
6,882
MRP 8,385
17% off